Correlation Between Protara Therapeutics and Miromatrix Medical
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Miromatrix Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Miromatrix Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Miromatrix Medical, you can compare the effects of market volatilities on Protara Therapeutics and Miromatrix Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Miromatrix Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Miromatrix Medical.
Diversification Opportunities for Protara Therapeutics and Miromatrix Medical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Protara and Miromatrix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Miromatrix Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Miromatrix Medical and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Miromatrix Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Miromatrix Medical has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Miromatrix Medical go up and down completely randomly.
Pair Corralation between Protara Therapeutics and Miromatrix Medical
Given the investment horizon of 90 days Protara Therapeutics is expected to generate 0.84 times more return on investment than Miromatrix Medical. However, Protara Therapeutics is 1.19 times less risky than Miromatrix Medical. It trades about 0.04 of its potential returns per unit of risk. Miromatrix Medical is currently generating about -0.05 per unit of risk. If you would invest 314.00 in Protara Therapeutics on November 2, 2024 and sell it today you would earn a total of 136.00 from holding Protara Therapeutics or generate 43.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Protara Therapeutics vs. Miromatrix Medical
Performance |
| Timeline |
| Protara Therapeutics |
| Miromatrix Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protara Therapeutics and Miromatrix Medical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protara Therapeutics and Miromatrix Medical
The main advantage of trading using opposite Protara Therapeutics and Miromatrix Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Miromatrix Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Miromatrix Medical will offset losses from the drop in Miromatrix Medical's long position.| Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology | Protara Therapeutics vs. Xilio Development |
| Miromatrix Medical vs. Anebulo Pharmaceuticals | Miromatrix Medical vs. Pmv Pharmaceuticals | Miromatrix Medical vs. Molecular Partners AG | Miromatrix Medical vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |